Developmental expression of cytochrome P450 enzymes in human liver

被引:95
作者
Hakkola, J
Tanaka, E
Pelkonen, O
机构
[1] Oulu Univ, Dept Pharmacol & Toxicol, FIN-90220 Oulu, Finland
[2] Univ Tsukuba, Inst Community Med, Tsukuba, Ibaraki 305, Japan
来源
PHARMACOLOGY & TOXICOLOGY | 1998年 / 82卷 / 05期
关键词
D O I
10.1111/j.1600-0773.1998.tb01427.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug-metabolizing cytochrome P450 enzymes, the major phase I enzymes, are active in human liver already at very early stages of intrauterine development, although presumably at fairly low concentrations and in low numbers. During maturation, these enzymes go through various developmental programmes towards adulthood. The major increase both in abundance as well as in number of different enzymes takes place after birth, probably during the first year of life. Detailed information concerning these developmental changes is still limited. The major drug-metabolizing P450 enzymes appear to be primarily members of the CYP3A subfamily in all stages of development. The balance between different members of this subfamily however, undergoes significant switches from the foetal predominant CYP3A7 to the major adult form CYP3A4. The ontogeny of the other cytochrome P450 enzymes is less well characterized, but the major switch-on appears to occur mainly after birth. Developmental expression of P450 enzymes is one of the key factors determining the pharmacokinetic status of developing individuals both pre-and postnatally.
引用
收藏
页码:209 / 217
页数:9
相关论文
共 84 条
[31]   CLINICAL PHARMACOKINETICS IN INFANTS AND CHILDREN - A REAPPRAISAL [J].
KEARNS, GL ;
REED, MD .
CLINICAL PHARMACOKINETICS, 1989, 17 :29-67
[32]   CYTOCHROME-P450 IN HUMAN FETAL LIVER - SIGNIFICANCE AND FETAL-SPECIFIC EXPRESSION [J].
KITADA, M ;
KAMATAKI, T .
DRUG METABOLISM REVIEWS, 1994, 26 (1-2) :305-323
[33]   4 FORMS OF CYTOCHROME-P-450 IN HUMAN FETAL LIVER - PURIFICATION AND THEIR CAPACITY TO ACTIVATE PROMUTAGENS [J].
KITADA, M ;
TANEDA, M ;
ITAHASHI, K ;
KAMATAKI, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (04) :426-432
[34]  
KITADA M, 1987, J BIOL CHEM, V262, P13534
[35]   SIGNIFICANCE OF CYTOCHROME-P-450 (P-450-HFLA) OF HUMAN-FETAL LIVERS IN THE STEROID AND DRUG OXIDATIONS [J].
KITADA, M ;
KAMATAKI, T ;
ITAHASHI, K ;
RIKIHISA, T ;
KANAKUBO, Y .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (04) :453-456
[36]   PURIFICATION AND PROPERTIES OF CYTOCHROME-P-450 FROM HOMOGENATES OF HUMAN-FETAL LIVERS [J].
KITADA, M ;
KAMATAKI, T ;
ITAHASHI, K ;
RIKIHISA, T ;
KATO, R ;
KANAKUBO, Y .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1985, 241 (01) :275-280
[37]   STABLE EXPRESSION OF CYTOCHROME-P450IIIA7 CDNA IN HUMAN BREAST-CANCER CELL-LINE MCF-7 AND ITS APPLICATION TO CYTOTOXICITY TESTING [J].
KITAMURA, R ;
SATO, K ;
SAWADA, M ;
ITOH, S ;
KITADA, M ;
KOMORI, M ;
KAMATAKI, T .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 292 (01) :136-140
[38]  
Klinger W., 1996, EXP TOXICOL PATHOL, V48, P1
[39]   FETUS-SPECIFIC EXPRESSION OF A FORM OF CYTOCHROME-P-450 IN HUMAN LIVERS [J].
KOMORI, M ;
NISHIO, K ;
KITADA, M ;
SHIRAMATSU, K ;
MUROYA, K ;
SOMA, M ;
NAGASHIMA, K ;
KAMATAKI, T .
BIOCHEMISTRY, 1990, 29 (18) :4430-4433
[40]   MOLECULAR-CLONING AND SEQUENCE-ANALYSIS OF CDNA CONTAINING THE ENTIRE CODING REGION FOR HUMAN-FETAL LIVER CYTOCHROME-P-450 [J].
KOMORI, M ;
NISHIO, K ;
OHI, H ;
KITADA, M ;
KAMATAKI, T .
JOURNAL OF BIOCHEMISTRY, 1989, 105 (02) :161-163